This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Align Technology, based in California, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position.
3 Cheap Stocks Under $10 to Buy Now for Coronavirus Reopening Rally
by Benjamin Rains
Today we look at three "cheap" stocks trading under $10 a share that might be worth buying as the market continues to march higher on coronavirus reopening optimism and more...
LH vs. ALGN: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
LH vs. ALGN: Which Stock Is the Better Value Option?
New Strong Sell Stocks for June 1st
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Align Technology (ALGN) Up 16% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Vertex Pharmaceuticals, Align Technology, Walmart, Home Depot and Target highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Vertex Pharmaceuticals, Align Technology, Walmart, Home Depot and Target highlighted as Zacks Bull and Bear of the Day
Bear of the Day: Align Technology (ALGN)
by Kevin Cook
Growth estimates have plummeted 30% but investors are finding value in shares near $200 on a $20B TAM
3 Cheap Stocks Under $10 to Buy for Continued Coronavirus Market Rally
by Benjamin Rains
Let's dive into three "cheap" stocks trading under $10 a share that investors might want to think about buying as the market continues its climb on coronavirus optimism...
New Strong Sell Stocks for May 5th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Company News for May 1, 2020
by Zacks Equity Research
Companies In The News Are: MCD, MSFT, ALGN, CHD.
Align Technology (ALGN) Q1 Earnings Miss, Margins Down
by Zacks Equity Research
Align Technology's (ALGN) Scanner and Services reports COVID-19-led lower sales in North America and APAC region.
Align Technology (ALGN) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Align Technology (ALGN) delivered earnings and revenue surprises of -31.78% and -6.25%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Medical Products Stock Earnings on Apr 29: BSX, ALGN & More
by Urmimala Biswas
Many Medical Product stocks might have succeeded in mitigating coronavirus-led downsides banking on huge market adoption of their COVID-19-related healthcare-support products.
Align Technology (ALGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Align Technology (ALGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Align Technology (ALGN) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Align Technology (ALGN) is expected to have gained from continued adoption of Invisalign system in the first two months of Q1.
New Strong Sell Stocks for April 14th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Align Technology Buys exocad to Expand Its Digital Platform
by Zacks Equity Research
Align Technology (ALGN) expands its portfolio with the buyout completion of exocad. This will help the company offer fully integrated workflows to dental labs and dental practices worldwide.
Align Technology Gets FDA Nod for iTero Intraoral Scanner
by Zacks Equity Research
The regulatory go-ahead is expected to help bolster Align Technolgy's (ALGN) iTero scanner and services business segment.
Align's High Invisalign Volume Stokes Growth Amid Cost Woes
by Zacks Equity Research
Stellar growth in Align Technology's (ALGN) Invisalign Go systems across all geographies continues.
Align Technology to Acquire exocad in Digital Dentistry Space
by Zacks Equity Research
This acquisition is expected to boost Align Technology's (ALGN) portfolio of Invisalign and iTero digital solutions.
3 MedTech Stocks to Rebound After Coronavirus-Led Recoil
by Sriparna Ghosal
As the coronavirus chaos continues to rise, MedTech firms have been witnessing a spike in demand for protective respiratory equipment.
Here's Why You Should Hold on to Align Technology for Now
by Zacks Equity Research
Investors continue to be optimistic about Align Technology (ALGN) on its strong segmental performance in Q4.
ABC or ALGN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ABC vs. ALGN: Which Stock Is the Better Value Option?
Why Is Align Technology (ALGN) Down 14.8% Since Last Earnings Report?
by Zacks Equity Research
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Bleak Outlook for Medical Dental Supplies Industry
by Sreyoshi Mukherjee
Despite digital dentistry and AI being dominant market trends, near-term prospects of the Dental industry look dull.
Align (ALGN) Rides on Volume Expansion Despite Cost Concerns
by Zacks Equity Research
We are upbeat about Align's (ALGN) consistent uptrend in Invisalign volumes across all geographies.